Compare Aurobindo Pharma with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ORCHID PHARMA AUROBINDO PHARMA/
ORCHID PHARMA
 
P/E (TTM) x 11.3 -20.3 - View Chart
P/BV x 1.5 1.9 79.5% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 AUROBINDO PHARMA   ORCHID PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
ORCHID PHARMA
Mar-21
AUROBINDO PHARMA/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0232,465 41.5%   
Low Rs33318 1,851.9%   
Sales per share (Unadj.) Rs422.8110.3 383.5%  
Earnings per share (Unadj.) Rs92.0-28.5 -322.2%  
Cash flow per share (Unadj.) Rs110.0-1.9 -5,896.6%  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs374.3159.9 234.0%  
Shares outstanding (eoy) m585.9440.82 1,435.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.611.3 14.2%   
Avg P/E ratio x7.4-43.5 -17.0%  
P/CF ratio (eoy) x6.2-665.6 -0.9%  
Price / Book Value ratio x1.87.8 23.3%  
Dividend payout %4.30-   
Avg Mkt Cap Rs m397,39850,677 784.2%   
No. of employees `000NANA-   
Total wages/salary Rs m35,350671 5,267.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m247,7464,501 5,504.7%  
Other income Rs m3,809152 2,501.3%   
Total revenues Rs m251,5554,653 5,406.5%   
Gross profit Rs m81,480294 27,745.4%  
Depreciation Rs m10,5541,089 969.0%   
Interest Rs m745522 142.7%   
Profit before tax Rs m73,990-1,165 -6,349.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,0980-   
Profit after tax Rs m53,892-1,165 -4,624.7%  
Gross profit margin %32.96.5 504.0%  
Effective tax rate %27.20-   
Net profit margin %21.8-25.9 -84.0%  
BALANCE SHEET DATA
Current assets Rs m198,2355,499 3,605.2%   
Current liabilities Rs m106,6521,421 7,506.3%   
Net working cap to sales %37.090.6 40.8%  
Current ratio x1.93.9 48.0%  
Inventory Days Days1920 96.4%  
Debtors Days Days521,101 4.7%  
Net fixed assets Rs m135,7786,874 1,975.3%   
Share capital Rs m586408 143.5%   
"Free" reserves Rs m218,7136,121 3,573.2%   
Net worth Rs m219,2996,529 3,358.8%   
Long term debt Rs m1,6844,275 39.4%   
Total assets Rs m334,01312,373 2,699.6%  
Interest coverage x100.3-1.2 -8,142.7%   
Debt to equity ratio x00.7 1.2%  
Sales to assets ratio x0.70.4 203.9%   
Return on assets %16.4-5.2 -314.6%  
Return on equity %24.6-17.8 -137.7%  
Return on capital %33.8-6.0 -568.0%  
Exports to sales %53.888.1 61.0%   
Imports to sales %16.437.3 44.0%   
Exports (fob) Rs m133,2483,966 3,359.4%   
Imports (cif) Rs m40,6151,677 2,421.7%   
Fx inflow Rs m133,2483,966 3,359.4%   
Fx outflow Rs m44,9461,729 2,599.1%   
Net fx Rs m88,3022,237 3,947.2%   
CASH FLOW
From Operations Rs m33,289236 14,114.0%  
From Investments Rs m5,987672 890.8%  
From Financial Activity Rs m-13,648-1,650 827.2%  
Net Cashflow Rs m25,831-742 -3,481.3%  

Share Holding

Indian Promoters % 48.8 90.0 54.2%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.3 4.6 829.0%  
FIIs % 20.8 1.6 1,293.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 10.0 481.7%  
Shareholders   338,639 33,698 1,004.9%  
Pledged promoter(s) holding % 14.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

SGX Nifty Trades Flat, Maruti Suzuki Acquires Stake in AI Firm, Zomato Q4 Results, and Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets failed to keep up early gains and ended marginally lower.

Related Views on News

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

Aurobindo Pharma's Stock Falls After Profits Decline 7% (Views On News)

Jun 1, 2021

Aurobindo Pharma shares fell nearly 4% after quarterly earnings disappoint.

Why Did Orchid Pharma Shares Plunge 10% Today? (Views On News)

Jun 25, 2021

Orchid Pharma shares plunge 10% as company fixes OFS price at 72% discount.

Orchid Pharma Shares Zoom 7,700% in Seven Months. More Gains Ahead? (Views On News)

Jun 3, 2021

Here's why Orchid Pharma shares have rallied 7,700% in seven months.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


May 23, 2022 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - UNICK FIX-A-FORM AND PRINTERS COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS